1-2 of 2
Kana Nakatani
Close
Sort by
Journal Articles

Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL -rearranged AML

Hidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, Yutarou Harata, Moe Higashitani, Yuri Ito, Yasuhiko Kamikubo, Yusuke Shiozawa, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Ai Okada, Yasuhito Nannya, June Takeda, Hiroo Ueno, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Satoru Miyano, Manja Meggendorfer, Claudia Haferlach, Seishi Ogawa, Souichi Adachi
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4623–4631.
https://doi.org/10.1182/bloodadvances.2020002457
Published: 2020
Includes: Supplemental data
Journal Articles

Recurrent CCND3 mutations in MLL -rearranged acute myeloid leukemia

Clinical Trials & Observations
Hidemasa Matsuo, Kenichi Yoshida, Kazutaka Fukumura, Kana Nakatani, Yuki Noguchi, Saho Takasaki, Mina Noura, Yusuke Shiozawa, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Ai Okada, Yasuhito Nannya, June Takeda, Hiroo Ueno, Norio Shiba, Genki Yamato, Hiroshi Handa, Yuichiro Ono, Nobuhiro Hiramoto, Takayuki Ishikawa, Kensuke Usuki, Ken Ishiyama, Shuichi Miyawaki, Hidehiro Itonaga, Yasushi Miyazaki, Machiko Kawamura, Hiroki Yamaguchi, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Yasuhide Hayashi, Hiroyuki Mano, Satoru Miyano, Yasuhiko Kamikubo, Seishi Ogawa, Souichi Adachi
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2879–2889.
https://doi.org/10.1182/bloodadvances.2018019398
Published: 2018
Includes: Supplemental data